Add to MyPages

This page will be saved to Cincinnati Children's MyPages, a collection of your favorite places. You can view, organize, or delete your favorites at any time.

 (optional)

E-mail this page

(All fields required)


Please enter a valid e-mail.

Please enter your name.

Please enter a valid e-mail.


Share this on:

Biographies

Kevin A. Hommel, PhD

Associate Professor, UC Department of Pediatrics

Phone: 513-803-0407

Fax: 513-803-0415

Email: kevin.hommel@cchmc.org

Show All

Specialties

Clinical Interests

Promotion of treatment adherence; self-management in pediatric chronic conditions

Research Interests

Adherence and self-management assessment methodology; behavioral treatment of nonadherence; promotion of self-management behavior; impact of adherence and self-management on health outcomes; quality of life in pediatric chronic conditions

Visit the Hommel Lab.

Biography

Kevin A. Hommel, PhD, is a research associate professor of Pediatrics in the Division of Behavioral Medicine and Clinical Psychology and the Center for the Promotion of Treatment Adherence and Self-Management. Dr. Hommel's research focuses on Adherence and self-management assessment methodology, behavioral treatment of nonadherence, promotion of self-management behavior, and the impact of adherence and self-management on health outcomes and quality of life in pediatric chronic conditions. His current research is in inflammatory bowel disease (IBD) and eosinophil-associated gastrointestinal disorders (EGID).

Dr. Hommel's research is currently funded by the National Institutes of Health (NIH) with a K23 Career Development Award and a R03 grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). These studies are focused on development, testing (via randomized controlled trial), and optimizing behavioral treatments for nonadherence in IBD. Additionally, Dr. Hommel is a co-investigator on a multisite study aimed at developing and testing a patient-provider collaborative chronic care network (C3N) to improve treatment outcomes in children with IBD. He is also a co-investigator on a study funded by the Children’s Digestive Health and Nutrition Foundation (CDHNF) focused on developing a disease-specific measure of health-related quality of life in eosinophilic esophagitis.

Dr. Hommel came to Cincinnati Children's Hospital Medical Center in 2008 from the Children's Hospital of Philadelphia and the University of Pennsylvania School of Medicine. He continues to collaborate with investigators at the Children's Hospital of Philadelphia as a site principal investigator on two studies funded by the NIDDK. The first is evaluating the efficacy of a low magnitude mechanical stimulus intervention to improve bone mineral density in children with Crohn's disease and the second is examining the effects of a novel lipid matrix supplement on choline status in children with cystic fibrosis.

Education and Training

BA: University of Central Oklahoma, 1996.

MS: Oklahoma State University,1999.

PhD: Oklahoma State University, 2002.

Residency
: Cincinnati Children's Hospital Medical Center, 2002.

Fellowship: Cincinnati Children's Hospital Medical Center, 2004.

Publications

View PubMed Publications

Grants

Behavioral Treatment of Nonadherence in Pediatric Inflammatory Bowel Disease. Principal Investigator. National Institute of Diabetes and Digestive and Kidney Diseases. 2007 - 2012. #K23 DK079037.

Promoting Treatment Adherence in Pediatric Inflammatory Bowel Disease. Principal Investigator. National Institute of Diabetes and Digestive and Kidney Diseases. 2010 - 2012. #R03 DK087822.

Open Source Science: Transforming Chronic Illness Care. Co-Investigator. National Institute of Diabetes and Digestive and Kidney Diseases / National Institute of Nursing Research. 2009 - 2014. #R01 DK085719.

Bone Health in Pediatric Crohn Disease: A Low Magnitude Mechanical Stimuli Trial. Principal Investigator. National Institute of Diabetes and Digestive and Kidney Disease. 2006 - 2011. #R01 DK073946.

Adherence to 6-Mercaptopurine/Azathiopurine and Quality of Life in Pediatric IBD. Principal Investigator. Prometheus Laboratories. 2008 - 2011.